• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals.

作者信息

von Gegerfelt A, Chiodi F, Keys B, Norkrans G, Hagberg L, Fenyö E M, Broliden K

机构信息

Department of Virology, Karolinska Institute, Stockholm, Sweden.

出版信息

AIDS Res Hum Retroviruses. 1992 Jun;8(6):1133-8. doi: 10.1089/aid.1992.8.1133.

DOI:10.1089/aid.1992.8.1133
PMID:1503825
Abstract

The cerebrospinal fluids (CSF) and sera from HIV-1-infected individuals at different clinical stages were monitored for neutralizing activity against CSF-derived HIV-1 isolates. None of the CSF samples and only one of seven serum samples could neutralize the autologous CSF isolate. CSF samples collected one to two years later from the same patients also lacked autologous neutralizing antibodies against these isolates. However, some CSF samples were able to neutralize heterologous CSF isolates albeit in low titers. HIV antibody positive control sera could readily neutralize all of the CSF isolates demonstrating that these isolates were not resistant to neutralization per se. IgG antibodies against the HIV-1 envelope protein and, specifically, against the V3 loop of HIV-1 gp120 (MN) were present in some CSF samples, although the samples lacked neutralizing activity. In summary, this study demonstrates a lack of autologous neutralizing antibodies in CSF samples when assayed against CSF-derived HIV-1 isolates.

摘要

相似文献

1
Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals.
AIDS Res Hum Retroviruses. 1992 Jun;8(6):1133-8. doi: 10.1089/aid.1992.8.1133.
2
High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.非洲和美洲血清中针对HIV-1MN主要中和决定簇gp120 V3区域的抗体高流行率。
AIDS Res Hum Retroviruses. 1991 Oct;7(10):831-8. doi: 10.1089/aid.1991.7.831.
3
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.1型人类免疫缺陷病毒ADA株gp120单体与gp140三聚体作为诱导中和抗体免疫原的比较
AIDS Res Hum Retroviruses. 2005 Jan;21(1):58-67. doi: 10.1089/aid.2005.21.58.
4
V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1.从受感染人类血清中亲和纯化的V3特异性多克隆抗体可有效中和1型人类免疫缺陷病毒的原始分离株。
AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1737-48. doi: 10.1089/08892220152741432.
5
The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.HIV-1感染患者中的大多数中和抗体识别线性V3环序列。使用HIV-1MN多种抗原肽的研究。
J Immunol. 1994 Aug 15;153(4):1895-904.
6
Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.人血清和兔抗V3肽血清对HIV-1原始分离株中和作用的比较研究。
J Med Virol. 1999 Oct;59(2):169-79.
7
Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.南非1型人类免疫缺陷病毒C亚型原始分离株上共享中和决定簇的区域聚类
J Virol. 2002 Mar;76(5):2233-44. doi: 10.1128/jvi.76.5.2233-2244.2002.
8
Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.人类免疫缺陷病毒1型感染期间的中和抗体反应:类型和组特异性以及病毒逃逸
J Gen Virol. 1993 May;74 ( Pt 5):855-63. doi: 10.1099/0022-1317-74-5-855.
9
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.抗V3/聚糖和抗膜近端外部区域(MPER)中和抗体,而非抗V2/聚糖位点抗体,与更强的抗HIV-1中和广度和效力密切相关。
J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11.
10
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity.检测来自人类免疫缺陷病毒1型(HIV-1)感染个体的血清,以寻找与对应HIV-1 gp120主要中和决定簇的肽发生反应的抗体,并检测其体外中和活性。
J Virol. 1992 Sep;66(9):5210-5. doi: 10.1128/JVI.66.9.5210-5215.1992.

引用本文的文献

1
Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.HIV-1 包膜相关的分子特征与 HIV 相关神经认知障碍。
Curr HIV/AIDS Rep. 2018 Feb;15(1):72-83. doi: 10.1007/s11904-018-0374-3.
2
Pathogenesis of human immunodeficiency virus infection.人类免疫缺陷病毒感染的发病机制
Microbiol Rev. 1993 Mar;57(1):183-289. doi: 10.1128/mr.57.1.183-289.1993.